Bausch Health Companies Statistics
Bausch Health Companies (BVF) Stock Statistics & Valuation Metrics
Total Valuation
Bausch Health Companies has a market cap or net worth of EUR 2.88B. The enterprise value is EUR 30.44B.
- Market Cap
- EUR 2.88B
- Enterprise Value
- EUR 30.44B
Share Statistics
Bausch Health Companies has 374,266,720 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 374,266,720
- Owned by Insiders
- 40.70%
- Owned by Institutions
- 45.35%
Financial Efficiency
Bausch Health Companies’s return on equity (ROE) is -0.29 and return on invested capital (ROIC) is 3.24%.
- Return on Equity (ROE)
- -0.29
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- 3.24%
- Return on Capital Employed (ROCE)
- 0.10
- Revenue Per Employee
- 514.57K
- Profits Per Employee
- 7,869.378
- Employee Count
- 20,300
- Asset Turnover
- 0.40
- Inventory Turnover
- 2.51
Valuation Ratios
The current PE Ratio of Bausch Health Companies is -3.85. Bausch Health Companies’s PEG ratio is 0.01.
- PE Ratio
- -3.85
- PS Ratio
- 0.29
- PB Ratio
- -2.47
- Price to FCF
- 1.79
- Price to Operating Cash Flow
- 1.48
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, Bausch Health Companies had revenue of 10.45B and earned 159.75M in profits. Earnings per share was 0.43.
- Revenue
- 10.45B
- Gross Profit
- 6.36B
- Operating Income
- 2.22B
- Pretax Income
- 373.42M
- Net Income
- 159.75M
- EBITDA
- 3.43B
- Earnings Per Share (EPS)
- 0.43
Cash Flow
In the last 12 months, operating cash flow was 2.21B and capital expenditures -384.29M, giving a free cash flow of 1.83B billion.
- Operating Cash Flow
- 2.21B
- Free Cash Flow
- 1.83B
- Free Cash Flow per Share
- 4.86
Dividends & Yields
Bausch Health Companies pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 55.68%
- Earnings Yield
- -25.55%
Stock Price Statistics
- Beta
- 1.21
- 52-Week Price Change
- 36.77%
- 50-Day Moving Average
- 5.76
- 200-Day Moving Average
- 4.83
- Relative Strength Index (RSI)
- 60.32
- Average Volume (3m)
- 890
Important Dates
Bausch Health Companies upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 28, 2026
- Next Earnings Date
- Feb 24, 2027
- Ex-Dividend Date
- ―
Financial Position
Bausch Health Companies as a current ratio of 1.47, with Debt / Equity ratio of -3835.02%
- Current Ratio
- 1.47
- Quick Ratio
- 1.08
- Debt to Market Cap
- 8.17
- Net Debt to EBITDA
- 5.80
- Interest Coverage Ratio
- 1.35
Taxes
In the past 12 months, Bausch Health Companies has paid 251.32M in taxes.
- Income Tax
- 251.32M
- Effective Tax Rate
- 0.67
Enterprise Valuation
Bausch Health Companies EV to EBITDA ratio is 9.00, with an EV/FCF ratio of 11.78.
- EV to Sales
- 1.94
- EV to EBITDA
- 9.00
- EV to Free Cash Flow
- 11.78
- EV to Operating Cash Flow
- 9.73
Balance Sheet
Bausch Health Companies has EUR 2.47B in cash and marketable securities with EUR 20.58B in debt, giving a net cash position of -EUR 18.11B billion.
- Cash & Marketable Securities
- EUR 2.47B
- Total Debt
- EUR 20.58B
- Net Cash
- -EUR 18.11B
- Net Cash Per Share
- -EUR 48.39
- Tangible Book Value Per Share
- -EUR 37.26
Margins
Gross margin is 72.62%, with operating margin of 27.97%, and net profit margin of -7.57%.
- Gross Margin
- 72.62%
- Operating Margin
- 27.97%
- Pretax Margin
- -3.18%
- Net Profit Margin
- -7.57%
- EBITDA Margin
- 21.51%
- EBIT Margin
- 11.16%
Analyst Forecast
The average price target for Bausch Health Companies is EUR 8.19, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- EUR 8.19
- Price Target Upside
- 12.75% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 3
- Revenue Growth Forecast
- 5.48%
- EPS Growth Forecast
- -325.38%
Scores
- Smart Score
- 8
- AI Score
- ―

